Kohei Hasegawa1, Jonathan M Mansbach, Stephen J Teach, Erin S Fisher, Daniel Hershey, Joyce Y Koh, Sunday Clark, Pedro A Piedra, Ashley F Sullivan, Carlos A Camargo. 1. From the *Department of Emergency Medicine, Massachusetts General Hospital; †Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA; ‡Division of Emergency Medicine, Children's National Health System, Washington, DC; §Department of Pediatrics, Rady Children's Hospital, University of California San Diego, San Diego; ¶Division of Hospital Medicine, Children's Hospital Los Angeles, Los Angeles, CA; ‖Department of Emergency Medicine, Weill Cornell Medical College, New York, NY; and **Departments of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX.
Abstract
BACKGROUND: It is unclear whether the infectious etiology of severe bronchiolitis affects short-term outcomes, such as posthospitalization relapse. We tested the hypothesis that children hospitalized with rhinovirus (RV) bronchiolitis, either as a sole pathogen or in combination with respiratory syncytial virus (RSV), are at increased risk of relapse. METHODS: We performed a 16-center, prospective cohort study of hospitalized children age <2 years with bronchiolitis. During the winters of 2007-2010, researchers collected clinical data and nasopharyngeal aspirates from study participants; the aspirates were tested using real-time polymerase chain reaction. The primary outcome was bronchiolitis relapse (urgent bronchiolitis visit or scheduled visit at which additions to the bronchiolitis medications were made) during the 2 weeks after hospital discharge. RESULTS: Among 1836 enrolled children with 2-week, follow-up data, the median age was 4 months and 60% were male. Overall, 48% had sole RSV infection, 8% had sole RV infection, and 13% had RSV/RV coinfection. Compared with children with sole RSV infection, and adjusting for 10 demographic and clinical characteristics and clustering of patients within hospitals, children with sole RV infection did not differ in their likelihood of relapse (odds ratio: 0.99; 95% confidence interval: 0.52-1.90; P = 0.98), whereas those with RSV/RV coinfection were more likely to have relapse (odds ratio: 1.54; 95% confidence interval: 1.03-2.30; P = 0.03). CONCLUSIONS: In this prospective, multicenter, multiyear study of children hospitalized with bronchiolitis, we found that RSV/RV coinfection was independently associated with a higher likelihood of bronchiolitis relapse. Present data support the concept that the infectious etiology of severe bronchiolitis affects short-term outcomes.
BACKGROUND: It is unclear whether the infectious etiology of severe bronchiolitis affects short-term outcomes, such as posthospitalization relapse. We tested the hypothesis that children hospitalized with rhinovirus (RV) bronchiolitis, either as a sole pathogen or in combination with respiratory syncytial virus (RSV), are at increased risk of relapse. METHODS: We performed a 16-center, prospective cohort study of hospitalized children age <2 years with bronchiolitis. During the winters of 2007-2010, researchers collected clinical data and nasopharyngeal aspirates from study participants; the aspirates were tested using real-time polymerase chain reaction. The primary outcome was bronchiolitis relapse (urgent bronchiolitis visit or scheduled visit at which additions to the bronchiolitis medications were made) during the 2 weeks after hospital discharge. RESULTS: Among 1836 enrolled children with 2-week, follow-up data, the median age was 4 months and 60% were male. Overall, 48% had sole RSV infection, 8% had sole RV infection, and 13% had RSV/RV coinfection. Compared with children with sole RSV infection, and adjusting for 10 demographic and clinical characteristics and clustering of patients within hospitals, children with sole RV infection did not differ in their likelihood of relapse (odds ratio: 0.99; 95% confidence interval: 0.52-1.90; P = 0.98), whereas those with RSV/RV coinfection were more likely to have relapse (odds ratio: 1.54; 95% confidence interval: 1.03-2.30; P = 0.03). CONCLUSIONS: In this prospective, multicenter, multiyear study of children hospitalized with bronchiolitis, we found that RSV/RV coinfection was independently associated with a higher likelihood of bronchiolitis relapse. Present data support the concept that the infectious etiology of severe bronchiolitis affects short-term outcomes.
Authors: Robert F Lemanske; Daniel J Jackson; Ronald E Gangnon; Michael D Evans; Zhanhai Li; Peter A Shult; Carol J Kirk; Erik Reisdorf; Kathy A Roberg; Elizabeth L Anderson; Kirstin T Carlson-Dakes; Kiva J Adler; Stephanie Gilbertson-White; Tressa E Pappas; Douglas F Dasilva; Christopher J Tisler; James E Gern Journal: J Allergy Clin Immunol Date: 2005-09 Impact factor: 10.793
Authors: Jonas M Winchell; Kathleen A Thurman; Stephanie L Mitchell; W Lanier Thacker; Barry S Fields Journal: J Clin Microbiol Date: 2008-07-09 Impact factor: 5.948
Authors: Daniel J Jackson; Ronald E Gangnon; Michael D Evans; Kathy A Roberg; Elizabeth L Anderson; Tressa E Pappas; Magnolia C Printz; Wai-Ming Lee; Peter A Shult; Erik Reisdorf; Kirsten T Carlson-Dakes; Lisa P Salazar; Douglas F DaSilva; Christopher J Tisler; James E Gern; Robert F Lemanske Journal: Am J Respir Crit Care Med Date: 2008-06-19 Impact factor: 21.405
Authors: Kecia N Carroll; Tebeb Gebretsadik; Marie R Griffin; Pingsheng Wu; William D Dupont; Edward F Mitchel; Rachel Enriquez; Tina V Hartert Journal: Pediatrics Date: 2008-07 Impact factor: 7.124
Authors: Krista L Yorita; Robert C Holman; James J Sejvar; Claudia A Steiner; Lawrence B Schonberger Journal: Pediatrics Date: 2008-02 Impact factor: 7.124
Authors: Jonathan M Mansbach; Alexander J McAdam; Sunday Clark; Paul D Hain; Robert G Flood; Uchechi Acholonu; Carlos A Camargo Journal: Acad Emerg Med Date: 2008-02 Impact factor: 3.451
Authors: Kohei Hasegawa; Jonathan M Mansbach; Nadim J Ajami; Janice A Espinola; David M Henke; Joseph F Petrosino; Pedro A Piedra; Chad A Shaw; Ashley F Sullivan; Carlos A Camargo Journal: Eur Respir J Date: 2016-10-06 Impact factor: 16.671
Authors: Kohei Hasegawa; Michelle D Stevenson; Jonathan M Mansbach; Alan R Schroeder; Ashley F Sullivan; Janice A Espinola; Pedro A Piedra; Carlos A Camargo Journal: Hosp Pediatr Date: 2015-07
Authors: Maria Arroyo; Kyle P Salka; Geovanny F Perez; Carlos E Rodriguez-Martinez; Jose A Castro-Rodriguez; Gustavo Nino Journal: J Investig Med Date: 2019-12-05 Impact factor: 2.895
Authors: Kohei Hasegawa; Brian M Pate; Jonathan M Mansbach; Charles G Macias; Erin S Fisher; Pedro A Piedra; Janice A Espinola; Ashley F Sullivan; Carlos A Camargo Journal: Acad Pediatr Date: 2015 Jan-Feb Impact factor: 3.107
Authors: Orianne Dumas; Jonathan M Mansbach; Tuomas Jartti; Kohei Hasegawa; Ashley F Sullivan; Pedro A Piedra; Carlos A Camargo Journal: Thorax Date: 2016-06-23 Impact factor: 9.139
Authors: Cheryl L Sargel; Mohammed Aboud; Aimee Forster; Loralie J Langman; Jessica Tansmore; Bruce A Mueller; William E Smoyer; Jeffery J Auletta Journal: J Pediatr Pharmacol Ther Date: 2018 Jul-Aug